14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 1.645 6 days ( -0.189 % )
Last Price $84.71 0.665 %
High/ Low $83.06 - $85.28 2.30%
Chg 7 Days 0.558 % $84.24 $84.71
Chg 30 Days 9.53 % $77.34 $84.71
Chg 12 mos -12.07 % $96.34 $84.71
Trend - 3 mos -11.10 % Width: 18.10 %
Trend - 12 mos -6.23 % Width: 33.00 %
Pred. range - 3 mos $63.74 - $75.28 -24.75 % - -11.14 %
Pred. range - 12 mos $67.77 - $90.13 -20.00 % - 6.40 %
Short MA avg 3 mos Buy May 31, 2024 - 14 days
Long MA avg 3 mos Buy Jun 05, 2024 - 11 days
Short/Long MA avg 3 mos Buy Jun 10, 2024 - 8 days
Short MA avg 12 mos Buy Jun 03, 2024 - 13 days
Long MA avg 12 mos Sell Apr 24, 2024 - 40 days
Short/Long MA avg 12 mos Sell Feb 15, 2024 - 87 days
Pivot Short Buy May 28, 2024 - 17 days
Bollinger Buy Jun 12, 2024 - 6 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT